Zoetis Receives Health Canada Approval for Portela to Alleviate Pain Associated with Osteoarthritis in Cats
Zoetis Receives European Commission Marketing Authorization for Lenivia® to Reduce Pain Associated with Osteoarthritis in Dogs
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
Zoetis Receives European Commission Marketing Authorization for Portela® to Alleviate Pain Associated with Osteoarthritis in Cats
